Recent advances in myocardial contrast echocardiography

Area of Science:

• Cardiovascular Imaging
• Medical Ultrasound Technology
• Echocardiography

Background:

• Recent advancements in contrast agents and ultrasound equipment have significantly improved Myocardial Contrast Echocardiography (MCE).
• Microbubble contrast agents now safely cross the pulmonary circulation, enhancing left ventricular opacification and endocardial border visualization.
• The utility of contrast echocardiography for improving image quality, especially in stress testing and intensive care, is well-established.

Purpose of the Study:

• This review focuses on the progress and applications of MCE in assessing myocardial perfusion for acute and chronic ischemic heart disease.
• To explore the expanding role of contrast echocardiography in clinical practice due to technological innovations.
• To briefly touch upon novel preclinical applications, such as targeted genetic and pharmaceutical material delivery.

Main Methods:

• Review of recent technological developments in microbubble ultrasound contrast agents.
• Analysis of advancements in ultrasound equipment enhancing MCE capabilities.
• Examination of clinical applications and research findings in myocardial perfusion assessment.

Main Results:

• MCE now provides improved endocardial border definition and myocardial perfusion detection.
• Contrast echocardiography is particularly effective in improving technically challenging images, especially in stress and ICU settings.
• Significant progress has been made in using MCE for diagnosing acute and chronic ischemic heart disease.

Conclusions:

• Technological innovations in ultrasound equipment and microbubble acoustics are expanding the clinical utility of contrast echocardiography.
• MCE plays a crucial role in the diagnosis and management of ischemic heart disease.
• Future research holds promise for novel applications of MCE in preclinical settings.